Showing results (1461-1470 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|August 2, 2011
Is adoptive T-cell therapy for solid tumors coming of age?P Pedrazzoli, P Comoli, D Montagna, et al.
Bone Marrow Transplantation|February 21, 2012
Attenuation of resting energy expenditure following hematopoietic SCT in childrenL J Bechard, H A Feldman, R Venick, et al.
Bone Marrow Transplantation|January 11, 2012
Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCTP Balasubramanian, S Desire, J C Panetta, et al.
Bone Marrow Transplantation|April 17, 2012
Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMTP Chevallier, M Labopin, N Milpied, et al.
Bone Marrow Transplantation|February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTR Devillier, R Crocchiolo, L Castagna, et al.
Bone Marrow Transplantation|February 7, 2012
High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCTR Tizon, N Frey, D F Heitjan, et al.
Bone Marrow Transplantation|March 8, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Bone Marrow Transplantation|October 21, 2014
Children as hematopoietic cell donors in research: when is it approvable?N N Shah, A S Wayne, C Grady, et al.
Bone Marrow Transplantation|November 12, 2014
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent yearsH W Auner, R Szydlo, J Hoek, et al.
Bone Marrow Transplantation|November 12, 2014
Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemiaN Jacque, S Nguyen, J-L Golmard, et al.
Pageof 993